These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12760875)

  • 1. In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis.
    Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrel KL; Fernandez H
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1963-7. PubMed ID: 12760875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of ABT-773, a new ketolide, against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.
    Goldstein EJ; Conrads G; Citron DM; Merriam CV; Warren Y; Tyrrell K
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2363-7. PubMed ID: 11451698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human serum activity of telithromycin, azithromycin and amoxicillin/clavulanate against common aerobic and anaerobic respiratory pathogens.
    Stein GE; Schooley S; Tyrrell KL; Citron DM; Goldstein EJ
    Int J Antimicrob Agents; 2007 Jan; 29(1):39-43. PubMed ID: 17189093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections.
    Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2525-9. PubMed ID: 10952607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of gemifloxacin compared to seven other oral antimicrobial agents against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.
    Goldstein EJ; Conrads G; Citron DM; Merriam CV; Warren Y; Tyrrell K
    Diagn Microbiol Infect Dis; 2002 Feb; 42(2):113-8. PubMed ID: 11858906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriological findings and antimicrobial resistance in odontogenic and non-odontogenic chronic maxillary sinusitis.
    Puglisi S; Privitera S; Maiolino L; Serra A; Garotta M; Blandino G; Speciale A
    J Med Microbiol; 2011 Sep; 60(Pt 9):1353-1359. PubMed ID: 21498651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans.
    Goldstein EJ; Citron DM; Hunt Gerardo S; Hudspeth M; Merriam CV
    Antimicrob Agents Chemother; 1998 May; 42(5):1127-32. PubMed ID: 9593139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activities of amoxicillin-clavulanate against aerobic and anaerobic bacteria isolated from antral puncture specimens from patients with sinusitis.
    Goldstein EJ; Citron DM; Merriam CV
    Antimicrob Agents Chemother; 1999 Mar; 43(3):705-7. PubMed ID: 10049296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria.
    Wexler HM; Molitoris E; Molitoris D; Finegold SM
    J Antimicrob Chemother; 2001 Apr; 47(4):467-9. PubMed ID: 11266423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes.
    Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2801-5. PubMed ID: 10543769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of ABT-492, a new fluoroquinolone, against 155 aerobic and 171 anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2003 Sep; 47(9):3008-11. PubMed ID: 12937015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
    Credito KL; Ednie LM; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2027-31. PubMed ID: 10428930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteria.
    Citron DM; Appleman MD
    Antimicrob Agents Chemother; 2001 Jan; 45(1):345-8. PubMed ID: 11120995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiology of the transition from acute to chronic maxillary sinusitis.
    Brook I; Frazier EH; Foote PA
    J Med Microbiol; 1996 Nov; 45(5):372-5. PubMed ID: 8918954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogens.
    Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2747-51. PubMed ID: 10991855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
    Walsh F; Carnegy F; Willcock J; Amyes S
    J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of telithromycin (HMR 3647) and seven other antimicrobial agents against anaerobic bacteria.
    Ackermann G; Schaumann R; Pless B; Claros MC; Rodloff AC
    J Antimicrob Chemother; 2000 Jul; 46(1):115-9. PubMed ID: 10882699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    J Antimicrob Chemother; 2002 Sep; 50(3):411-20. PubMed ID: 12205068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of telithromycin and azithromycin on nasopharyngeal bacterial flora in patients with acute maxillary sinusitis.
    Brook I; Hausfeld JN
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):442-5. PubMed ID: 16618915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.